References
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
- Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 1995;22:1974–5.
- Backhaus M, Burmester GR, Sandrock D, Loreck D, Hess D, Scholz A, Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 2002;61:895–904.
- De Schrijver M, Streule K, Senekowitsch R, Fridrich R. Scintigraphy of inflammation with nanometer-sized colloid tracer. Nucl Med Commun 1987;8:895–908.
- Liberatore M, Clemente M, Iurilli AP, Zorzin L, Marini M, Di Rocco E, Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloids. Eur J Nucl Med 1992;19:853–7.
- Adams BK, AL Attia HM, Khadim RA, Al Haider ZY. 99Tcm nanocolloid scintigraphy: a reliable way to detect active joint disease in patients with peripheral joint pain. Nucl Med Commun 2001;22:315–18.
- Takalo R, Karjalainen A, Ahonen A, Niemelä RK, Kautiainen H, Hakala M. Comparison of 99m technetium nanocolloid scintigraphy with 99m technetium human immunoglobulin G scintigraphy in the differentiation of inflammatory joint disorders in patients with joint pain. Clin Exp Rheumatol 2008;26:711.
- De Bois MHW, Westedt M-L, Arndt JW, Wiarda KS, Van Der Velde EA, Pauwels EKJ, Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset. Rheumatol Int 1995;15:155–8.
- Chianelli M, D'Alessandria C, Conti F, Priori R, Valesigni G, Annovazzi A, New pharmaceuticals for imaging rheumatoid arthritis. Q J Nucl Med 2006;50:217–25.